Literature DB >> 11785689

Contributions of electromigration and electroosmosis to iontophoretic drug delivery.

D Marro1, Y N Kalia, M B Delgado-Charro, R H Guy.   

Abstract

PURPOSE: To determine the electromigration and electroosmotic contributions to the iontophoretic delivery of lidocaine hydrochloride, in addition to the more-lipophilic quinine and propranolol hydrochlorides, in the presence and absence of background electrolyte.
METHODS: In vitro experiments, using excised pig ear skin and both vertical and side-by-side diffusion cells, were performed as a function of drug concentration and with and without background electrolytes in the anodal formulation. Concomitantly, the contribution of electroosmosis in each experimental configuration was monitored by following the transport of the neutral, polar marker molecule, mannitol.
RESULTS: Electromigration was the dominant mechanism of drug iontophoresis (typically representing approximately 90% of the total flux). In the presence of background electrolyte, lidocaine delivery increased linearly with concentration as it competed more and more effectively with Na+ to carry the charge across the skin. However, iontophoretic delivery of quinine and propranolol increased non-linearly with concentration. Without electrolytes, on the other hand, electrotransport of the three drugs was essentially independent of concentration over the range 1-100 mM. Transport efficiency of lidocaine was approximately 10%, whereas that of the more lipophilic compounds was significanly less, with the major charge carrier being Cl- moving from beneath the skin into the anodal chamber. Both quinine and propranolol induced a concentration-dependent attenuation of electroosmotic flow in the normal anode-to-cathode direction.
CONCLUSION: Dissecting apart the mechanistic contributions to iontophoretic drug delivery is key to the optimization of the formulation, and to the efficient use of the drug substance.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11785689     DOI: 10.1023/a:1013318412527

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  15 in total

1.  Visualization and analysis of electroosmotic flow in hairless mouse skin.

Authors:  B D Bath; H S White; E R Scott
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

2.  Epidermal iontophoresis: II. Application of the ionic mobility-pore model to the transport of local anesthetics.

Authors:  P M Lai; M S Roberts
Journal:  Pharm Res       Date:  1998-10       Impact factor: 4.200

3.  Transdermal delivery of peptides by iontophoresis.

Authors:  J Hirvonen; Y N Kalia; R H Guy
Journal:  Nat Biotechnol       Date:  1996-12       Impact factor: 54.908

4.  Iontophoretic delivery across the skin: electroosmosis and its modulation by drug substances.

Authors:  J Hirvonen; R H Guy
Journal:  Pharm Res       Date:  1997-09       Impact factor: 4.200

5.  Characterization of the iontophoretic permselectivity properties of human and pig skin.

Authors:  D Marro; R H Guy; M B Delgado-Charro
Journal:  J Control Release       Date:  2001-01-29       Impact factor: 9.776

6.  Electrorepulsion versus electroosmosis: effect of pH on the iontophoretic flux of 5-fluorouracil.

Authors:  V Merino; A López; Y N Kalia; R H Guy
Journal:  Pharm Res       Date:  1999-05       Impact factor: 4.200

7.  Convective solvent flow across the skin during iontophoresis.

Authors:  A Kim; P G Green; G Rao; R H Guy
Journal:  Pharm Res       Date:  1993-09       Impact factor: 4.200

8.  Characterization of convective solvent flow during iontophoresis.

Authors:  M B Delgado-Charro; R H Guy
Journal:  Pharm Res       Date:  1994-07       Impact factor: 4.200

9.  Optimizing iontophoretic drug delivery: identification and distribution of the charge-carrying species.

Authors:  D Marro; Y N Kalia; M B Delgado-Charro; R H Guy
Journal:  Pharm Res       Date:  2001-12       Impact factor: 4.200

10.  Transdermal iontophoresis: modulation of electroosmosis by polypeptide.

Authors:  J Hirvonen; R H Guy
Journal:  J Control Release       Date:  1998-01-02       Impact factor: 9.776

View more
  23 in total

1.  Iontophoresis-facilitated delivery of prednisolone through throat skin to the trachea after topical application of its succinate salt.

Authors:  Hiroshi Ishii; Tsukasa Suzuki; Hiroaki Todo; Mitsuhiro Kamimura; Kenji Sugibayashi
Journal:  Pharm Res       Date:  2010-12-23       Impact factor: 4.200

2.  Transdermal iontophoretic delivery of vapreotide acetate across porcine skin in vitro.

Authors:  Yannic B Schuetz; Aarti Naik; Richard H Guy; Evelyne Vuaridel; Yogeshvar N Kalia
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

3.  Iontophoretic skin permeation of peptides: an investigation into the influence of molecular properties, iontophoretic conditions and formulation parameters.

Authors:  Gayathri Krishnan; Michael S Roberts; Jeffrey Grice; Yuri G Anissimov; Hamid R Moghimi; Heather A E Benson
Journal:  Drug Deliv Transl Res       Date:  2014-06       Impact factor: 4.617

4.  Dermal, subdermal, and systemic concentrations of granisetron by iontophoretic delivery.

Authors:  Ayyappa Chaturvedula; Dipty P Joshi; Carter Anderson; Russ Morris; Walter L Sembrowich; Ajay K Banga
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

5.  Iontophoresis of dexamethasone phosphate: competition with chloride ions.

Authors:  J-P Sylvestre; C Díaz-Marín; M B Delgado-Charro; R H Guy
Journal:  J Control Release       Date:  2008-07-06       Impact factor: 9.776

6.  Mechanistic study of electroosmotic transport across hydrated nail plates: effects of pH and ionic strength.

Authors:  Jinsong Hao; S Kevin Li
Journal:  J Pharm Sci       Date:  2008-12       Impact factor: 3.534

7.  Reverse iontophoresis as a noninvasive tool for lithium monitoring and pharmacokinetic profiling.

Authors:  Benoît Leboulanger; Marc Fathi; Richard H Guy; M Begoña Delgado-Charro
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

8.  Transdermal delivery by iontophoresis.

Authors:  Swati Rawat; Sudha Vengurlekar; B Rakesh; S Jain; G Srikarti
Journal:  Indian J Pharm Sci       Date:  2008-01       Impact factor: 0.975

9.  Transdermal reverse iontophoresis of valproate: a noninvasive method for therapeutic drug monitoring.

Authors:  M Begoña Delgado-Charro; Richard H Guy
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

10.  Transdermal delivery of cytochrome C--A 12.4 kDa protein--across intact skin by constant-current iontophoresis.

Authors:  J Cázares-Delgadillo; A Naik; A Ganem-Rondero; D Quintanar-Guerrero; Y N Kalia
Journal:  Pharm Res       Date:  2007-04-25       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.